AAAAAA

   
Results: 1-10 |
Results: 10
DNA-DAMAGE IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS CORRELATES WITH RESPONSE TO BIOCHEMOTHERAPY IN MELANOMA
Authors: BUZAID AC ALIOSMAN F AKANDE N GRIMM EA LEE JJ BEDIKIAN A ETON O PAPADOPOULOS N PLAGER C LEGHA SS BENJAMIN RS
Citation: Ac. Buzaid et al., DNA-DAMAGE IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS CORRELATES WITH RESPONSE TO BIOCHEMOTHERAPY IN MELANOMA, Melanoma research, 8(2), 1998, pp. 145-148
NITRIC-OXIDE AND NEOPTERIN LEVELS AND CLINICAL-RESPONSE IN STAGE-III MELANOMA PATIENTS RECEIVING CONCURRENT BIOCHEMOTHERAPY
Authors: ANDERSON CM BUZAID AC SUSSMAN J LEE JJ ALIOSMAN F BRAUNSCHWEIGER PG PLAGER C BEDIKIAN A PAPADOPOULOS N ETON O LEGHA SS GRIMM EA
Citation: Cm. Anderson et al., NITRIC-OXIDE AND NEOPTERIN LEVELS AND CLINICAL-RESPONSE IN STAGE-III MELANOMA PATIENTS RECEIVING CONCURRENT BIOCHEMOTHERAPY, Melanoma research, 8(2), 1998, pp. 149-155
DEVELOPMENT OF A BIOCHEMOTHERAPY REGIMEN WITH CONCURRENT ADMINISTRATION OF CISPLATIN, VINBLASTINE, DACARBAZINE, INTERFERON-ALPHA, AND INTERLEUKIN-2 FOR PATIENTS WITH METASTATIC MELANOMA
Authors: LEGHA SS RING S ETON O BEDIKIAN A BUZAID AC PLAGER C PAPADOPOULOS N
Citation: Ss. Legha et al., DEVELOPMENT OF A BIOCHEMOTHERAPY REGIMEN WITH CONCURRENT ADMINISTRATION OF CISPLATIN, VINBLASTINE, DACARBAZINE, INTERFERON-ALPHA, AND INTERLEUKIN-2 FOR PATIENTS WITH METASTATIC MELANOMA, Journal of clinical oncology, 16(5), 1998, pp. 1752-1759
DEVELOPMENT AND RESULTS OF BIOCHEMOTHERAPY IN METASTATIC MELANOMA - THE UNIVERSITY-OF-TEXAS-M.D.-ANDERSON-CANCER-CENTER EXPERIENCE
Authors: LEGHA SS RING S ETON O BEDIKIAN A PLAGER C PAPADOPOULOS N
Citation: Ss. Legha et al., DEVELOPMENT AND RESULTS OF BIOCHEMOTHERAPY IN METASTATIC MELANOMA - THE UNIVERSITY-OF-TEXAS-M.D.-ANDERSON-CANCER-CENTER EXPERIENCE, The cancer journal from Scientific American, 3, 1997, pp. 9-15
CRITICAL ANALYSIS OF THE CURRENT AMERICAN JOINT COMMITTEE ON CANCER STAGING SYSTEM FOR CUTANEOUS MELANOMA AND PROPOSAL OF A NEW STAGING SYSTEM
Authors: BUZAID AC ROSS MI BALCH CM SOONG SJ MCCARTHY WH TINOCO L MANSFIELD P LEE JE BEDIKIAN A ETON O PLAGER C PAPADOPOULOS N LEGHA SS BENJAMIN RS
Citation: Ac. Buzaid et al., CRITICAL ANALYSIS OF THE CURRENT AMERICAN JOINT COMMITTEE ON CANCER STAGING SYSTEM FOR CUTANEOUS MELANOMA AND PROPOSAL OF A NEW STAGING SYSTEM, Journal of clinical oncology, 15(3), 1997, pp. 1039-1051
TREATMENT OF METASTATIC MELANOMA WITH COMBINED CHEMOTHERAPY CONTAINING CISPLATIN, VINBLASTINE AND DACARBAZINE (CVD) AND BIOTHERAPY USING INTERLEUKIN-2 AND INTERFERON-ALPHA
Authors: LEGHA SS RING S BEDIKIAN A PLAGER C ETON O BUZAID AC PAPADOPOULOS N
Citation: Ss. Legha et al., TREATMENT OF METASTATIC MELANOMA WITH COMBINED CHEMOTHERAPY CONTAINING CISPLATIN, VINBLASTINE AND DACARBAZINE (CVD) AND BIOTHERAPY USING INTERLEUKIN-2 AND INTERFERON-ALPHA, Annals of oncology, 7(8), 1996, pp. 827-835
MECHANISM OF THE ANTITUMOR EFFECT OF BIOCHEMOTHERAPY IN MELANOMA - PRELIMINARY-RESULTS
Authors: BUZAID AC GRIMM EA ALIOSMAN F RING S ETON O PAPADOPOULOS NE BEDIKIAN A PLAGER C LEGHA SS BENJAMIN R
Citation: Ac. Buzaid et al., MECHANISM OF THE ANTITUMOR EFFECT OF BIOCHEMOTHERAPY IN MELANOMA - PRELIMINARY-RESULTS, Melanoma research, 4(5), 1994, pp. 327-330
PHARMACOKINETICS OF MEROPENEM IN PATIENTS WITH INTRAABDOMINAL INFECTIONS
Authors: BEDIKIAN A OKAMOTO MP NAKAHIRO RK FARINO J HESELTINE PNR APPLEMAN MD YELLIN AE BERNE TV GILL MA
Citation: A. Bedikian et al., PHARMACOKINETICS OF MEROPENEM IN PATIENTS WITH INTRAABDOMINAL INFECTIONS, Antimicrobial agents and chemotherapy, 38(1), 1994, pp. 151-154
CEFEPIME - A NEW 4TH-GENERATION CEPHALOSPORIN
Authors: OKAMOTO MP NAKAHIRO RK CHIN A BEDIKIAN A GILL MA
Citation: Mp. Okamoto et al., CEFEPIME - A NEW 4TH-GENERATION CEPHALOSPORIN, American journal of hospital pharmacy, 51(4), 1994, pp. 463-477
CEFEPIME CLINICAL PHARMACOKINETICS
Authors: OKAMOTO MP NAKAHIRO RK CHIN A BEDIKIAN A
Citation: Mp. Okamoto et al., CEFEPIME CLINICAL PHARMACOKINETICS, Clinical pharmacokinetics, 25(2), 1993, pp. 88-102
Risultati: 1-10 |